Moreover, two other TRIM proteins (TRIM33 and TRIM24) have been reported as oncogene or oncogenic transcriptional activators in B-cell leukemias and prostate cancer, respectively [26, 27]. This evidence concerns the gene TRIM24 and prostate cancer.